Related Experiment Videos

Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors

M Pieretti1, D E Powell, H H Gallion

  • 1Department of Pathology, Markey Cancer Center, University of Kentucky Medical Center, Lexington 40536-0093, USA.

Human Pathology
|April 1, 1995
PubMed

Insights

Loss of chromosome 17 is common in epithelial ovarian tumors, particularly serous types. This genetic event may explain different ovarian cancer subtypes and their aggressiveness.

Area of Science:

  • Oncology
  • Genetics
  • Gynecologic Pathology

Background:

  • Epithelial ovarian tumors are common in adult women, presenting diverse histological patterns and aggressiveness.
  • Molecular genetic studies indicate loss of heterozygosity (LOH) on chromosome 17 is frequent in epithelial ovarian cancer, suggesting tumor suppressor gene inactivation.

Purpose of the Study:

  • To investigate the frequency and patterns of chromosome 17 LOH in sporadic epithelial ovarian tumors.
  • To determine if LOH on chromosome 17 correlates with specific histological subtypes of ovarian cancer.

Main Methods:

  • Analysis of 87 sporadic epithelial ovarian tumors of varying grades and histological types.
  • Examination of LOH at 16 specific loci on chromosome 17.

Main Results:

  • Loss of heterozygosity (LOH) for chromosome 17 was observed in 35% of the epithelial ovarian tumors studied.
  • A significant majority (84%) of tumors with LOH showed loss across all informative markers, suggesting whole chromosome loss.
  • Chromosome 17 loss was significantly more frequent in serous tumors (49%) compared to endometrioid (15%) and mucinous (4%) subtypes.

Conclusions:

  • The findings support the hypothesis that distinct molecular genetic events, including chromosome 17 loss, underlie the different histological subtypes of epithelial ovarian cancer.
  • Chromosome 17 alterations are a key feature in the pathogenesis of specific epithelial ovarian cancer subtypes.

Related Concept Videos